DK0561780T3 - Lipid-afhængige diagnostiske assays - Google Patents

Lipid-afhængige diagnostiske assays

Info

Publication number
DK0561780T3
DK0561780T3 DK91902056.0T DK91902056T DK0561780T3 DK 0561780 T3 DK0561780 T3 DK 0561780T3 DK 91902056 T DK91902056 T DK 91902056T DK 0561780 T3 DK0561780 T3 DK 0561780T3
Authority
DK
Denmark
Prior art keywords
assay
phospholipid
suspension
sample
lipid
Prior art date
Application number
DK91902056.0T
Other languages
Danish (da)
English (en)
Inventor
Andrew S Janoff
Joyce Rauch
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of DK0561780T3 publication Critical patent/DK0561780T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK91902056.0T 1990-12-07 1990-12-28 Lipid-afhængige diagnostiske assays DK0561780T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62334090A 1990-12-07 1990-12-07

Publications (1)

Publication Number Publication Date
DK0561780T3 true DK0561780T3 (da) 1996-12-09

Family

ID=24497709

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91902056.0T DK0561780T3 (da) 1990-12-07 1990-12-28 Lipid-afhængige diagnostiske assays

Country Status (10)

Country Link
EP (1) EP0561780B1 (de)
JP (1) JP2983630B2 (de)
AT (1) ATE140798T1 (de)
AU (1) AU648775B2 (de)
CA (1) CA2095928C (de)
DE (1) DE69027936T2 (de)
DK (1) DK0561780T3 (de)
ES (1) ES2090306T3 (de)
GR (1) GR3021412T3 (de)
WO (1) WO1992010586A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
JP4377207B2 (ja) * 2003-11-28 2009-12-02 シスメックス株式会社 血液凝固時間測定方法および血液凝固時間測定用試薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543339A (en) * 1982-03-16 1985-09-24 Oneill Christopher Early pregnancy detection by detecting enhanced blood platelet activation
US4666831A (en) * 1985-02-19 1987-05-19 The Liposome Company, Inc. Lipid-dependent diagnostic assays
US4698299A (en) * 1985-02-19 1987-10-06 The Liposome Company, Inc. Lipid-dependent diagnostic assays
ATE82397T1 (de) * 1987-08-13 1992-11-15 Synbiotics Corp Bestimmungen einer amphipathischen substanz durch verwendung einer lipophilen oberflaeche.
US4877741A (en) * 1988-10-24 1989-10-31 The United States Of America As Represented By The Secretary Of The Air Force Treatment of human plasma with brown recluse spider toxin to emulate a lupus anticoagulant

Also Published As

Publication number Publication date
AU7162091A (en) 1992-07-08
CA2095928A1 (en) 1992-06-08
DE69027936D1 (de) 1996-08-29
EP0561780A1 (de) 1993-09-29
ATE140798T1 (de) 1996-08-15
DE69027936T2 (de) 1997-03-06
CA2095928C (en) 1999-08-31
WO1992010586A1 (en) 1992-06-25
JP2983630B2 (ja) 1999-11-29
EP0561780B1 (de) 1996-07-24
GR3021412T3 (en) 1997-01-31
AU648775B2 (en) 1994-05-05
JPH06503640A (ja) 1994-04-21
ES2090306T3 (es) 1996-10-16
EP0561780A4 (de) 1994-08-03

Similar Documents

Publication Publication Date Title
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
SE8008952L (sv) Forfarande och anordning for bestemning av serumlipoproteiner
BR9811406A (pt) Dispositivo para detenção da presença de pelo menos um analito em uma amostra biológica, kit para detenção da presença de pelo menos um analito em uma amostra biológica, e, processo de detecção da presença de pelo menos um analito em uma amostra biológica
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
Takikawa et al. Usefulness and accuracy of the international normalized ratio and activity percent of prothrombin time in patients with liver disease
DK0561780T3 (da) Lipid-afhængige diagnostiske assays
ES2067024T3 (es) Metodo y kit para determinar actividades fosforilantes y desfosforilantes de tirosina.
Wood et al. Reproducibility of serological titers
MXPA02012176A (es) Un metodo para detectar un complejo de liproproteina -proteina de fase aguda y predecir un riesgo mayor de falla de sistema o mortalidad.
Kubasik et al. Radioimmunoassay of serum myoglobin: evaluation and modification of a commercial kit and assessment of its usefulness for detecting acute myocardial infarction.
Liu et al. Immunochemical determination of LDH-1
Elyas et al. Valproic acid estimation by enzyme immunoassay
EP0352139A3 (de) Antikörper- oder Antigenen-Detektion
Cobbaert et al. Different effects of Intralipid and triacylglycerol rich lipoproteins on Kodak Ektachem serum cholesterol determination
ATE242487T1 (de) Verfahren zur bestimmung von schilddrüsen- autoantikörpern
Edelman et al. Evaluation of the new Beckman electrophoretic method for CK-MB: comparison with ion exchange chromatography and investigation of a reference outpatient population
KR950009257A (ko) 골다공증 진단제
Hoffmann et al. Serological distance coefficients
US3733398A (en) Determining and reversing anticomplementary activity in complement fixation test for australia antigen
Freudenrich et al. The effects of adrenalectomy on the alpha-adrenergic regulation of cytosolic free calcium in hepatocytes.
Swinne et al. Detection of circulating capsular polysaccharide antigen from Cryptococcus neoformans
EP0615128A2 (de) Vorrichtung und Test zur Bestimmung eines Antigens oder eines Antikörpers in einer Testprobe
Whitehead et al. The detection of fetal hemoglobin in bloodstains by means of thin-layer immunoassay
Dorigo-Zetsma et al. Performance of Meridian ImmunoCard Mycoplasma Test in a multicenter clinical trial